Discrepancy between glucose metabolism and sympathetic nerve terminals in a patient with metastatic paraganglioma

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 35, Issue 3, 2008, Pages 687-

  Rahbar, Kambiz ^a   Kies, Peter ^a   Stegger, Lars ^a   Juergens, Kai Uwe ^a   Weckesser, Matthias ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; FLUORODEOXYGLUCOSE F 18;

ABDOMINAL TUMOR; ADULT; ARTICLE; CANCER PATIENT; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; GLUCOSE METABOLISM; HUMAN; MALE; METASTASIS; PARAGANGLIOMA; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPATHETIC NERVE;

3-IODOBENZYLGUANIDINE; ABDOMINAL NEOPLASMS; ADULT; BLOOD GLUCOSE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; PARAGANGLIOMA; SYMPATHETIC NERVOUS SYSTEM;

EID: 43349085374     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-007-0646-4     Document Type: Article

References (2)

1. 11C-meta-hydroxyephedrine in tumors of the sympathetic nervous system: feasibility study and comparison with 123I-MIBG SPECT/CT. J Nucl Med 2006;47:1635-42.
2. Mamede M, Carrasquillo JA, Chen CC, Del Corral P, Whatley M, Ilias I, et al. Discordant localization of 2-[18F]-fluoro-2-deoxy-d-glucose in 6-[18F]-fluorodopamine- and [(123)I]-metaiodobenzylguanidine-negative metastatic pheochromocytoma sites. Nucl Med Commun 2006;27:31-6.